Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Intellect Design Arena introduces iGPX AI-powered public procurement platform Intellect Design Arena Ltd, a leading FinTech company renowned for its innovative solutions in banking and insurance, has… byPallavi MadhirajuJuly 4, 2024